Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Actionable molecular alterations in newly diagnosed and recurrent IDH1/2 wild-type glioblastoma patients and therapeutic implications: a large mono-institutional experience using extensive next-generation sequencing analysis.
Eur J Cancer. 2023 Sep;191:112959. doi: 10.1016/j.ejca.2023.112959. Epub 2023 Jun 22.
Eur J Cancer. 2023.
PMID: 37481865
Free article.
Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study.
Bosio A, Cerretti G, Padovan M, Caccese M, Denaro L, Chioffi F, Della Puppa A, Aldegheri V, Guarneri V, Zagonel V, Lombardi G.
Bosio A, et al.
Clin Oncol (R Coll Radiol). 2023 May;35(5):e319-e327. doi: 10.1016/j.clon.2023.01.012. Epub 2023 Feb 2.
Clin Oncol (R Coll Radiol). 2023.
PMID: 36858930
Free article.
Item in Clipboard
Cite
Cite